Ismaila M, Lall K, Sookram K, Sundaram V, Jones K
Scientifica (Cairo). 2024; 2024:1545153.
PMID: 39618689
PMC: 11606660.
DOI: 10.1155/sci5/1545153.
Mauriz E, Fernandez-Vazquez J, Diez-Flecha C, Reguero-Celada S, Fernandez-Villa T, Fernandez-Somoano A
Vaccines (Basel). 2023; 11(8).
PMID: 37631950
PMC: 10459698.
DOI: 10.3390/vaccines11081382.
Hernandez Bautista P, Grajales Muniz C, Cabrera Gaytan D, Rojas Mendoza T, Vallejos Paras A, Santacruz Tinoco C
PLoS One. 2023; 18(8):e0265698.
PMID: 37535644
PMC: 10399771.
DOI: 10.1371/journal.pone.0265698.
Kalodimou G, Jany S, Freudenstein A, Schwarz J, Limpinsel L, Rohde C
Viruses. 2023; 15(5).
PMID: 37243266
PMC: 10222707.
DOI: 10.3390/v15051180.
Andrejko K, Pry J, Myers J, Mehrotra M, Lamba K, Lim E
Am J Epidemiol. 2023; 192(6):895-907.
PMID: 36702469
PMC: 10236522.
DOI: 10.1093/aje/kwad017.
Hospitalization among vaccines for SARS-CoV-2 breakthrough infection after dose sparing strategies in Libya: A cohort study.
Abdelhamid M, Almsellati I, Annajar B, Abdulhamid A, Alemam H, Etikar M
PLoS One. 2022; 17(11):e0276425.
PMID: 36327290
PMC: 9632805.
DOI: 10.1371/journal.pone.0276425.
Mechanistic Models of COVID-19: Insights into Disease Progression, Vaccines, and Therapeutics.
Desikan R, Padmanabhan P, Kierzek A, van der Graaf P
Int J Antimicrob Agents. 2022; 60(1):106606.
PMID: 35588969
PMC: 9110059.
DOI: 10.1016/j.ijantimicag.2022.106606.
COVID-19 vaccination challenges: A mini-review.
Mohseni Afshar Z, Barary M, Hosseinzadeh R, Karim B, Ebrahimpour S, Nazary K
Hum Vaccin Immunother. 2022; 18(5):2066425.
PMID: 35512088
PMC: 9302531.
DOI: 10.1080/21645515.2022.2066425.
How the COVID 19 pandemic will shape influenza public health initiatives: The UK experience.
Ashraf M, Rajaram S, English P
Hum Vaccin Immunother. 2022; 18(5):2056399.
PMID: 35435806
PMC: 9255027.
DOI: 10.1080/21645515.2022.2056399.
Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data.
Vasileiou E, Shi T, Kerr S, Robertson C, Joy M, Tsang R
BMJ Open. 2022; 12(2):e050062.
PMID: 35165107
PMC: 8844955.
DOI: 10.1136/bmjopen-2021-050062.
Should We Delay the Second COVID-19 Vaccine Dose in Order to Optimize Rollout? A Mathematical Perspective.
Berkane S, Harizi I, Tayebi A, Silverman M, Stranges S
Int J Public Health. 2022; 66:1604312.
PMID: 35140580
PMC: 8820268.
DOI: 10.3389/ijph.2021.1604312.
Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants.
Zhang R, Liu D, Leung K, Fan Y, Lu L, Chan P
Vaccines (Basel). 2022; 10(1).
PMID: 35062734
PMC: 8781520.
DOI: 10.3390/vaccines10010072.
Modelling policy combinations of vaccination and transmission suppression of SARS-CoV-2 in Rio de Janeiro, Brazil.
Valiati N, Villela D
Infect Dis Model. 2022; 7(1):231-242.
PMID: 35005325
PMC: 8719375.
DOI: 10.1016/j.idm.2021.12.007.
Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021.
Cheng C, Lu C, Chang Y, Sun Y, Chu H, Lee C
Vaccines (Basel). 2021; 9(12).
PMID: 34960235
PMC: 8708265.
DOI: 10.3390/vaccines9121489.
Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic.
Yap C, Ali A, Prabhakar A, Prabhakar A, Pal A, Lim Y
Ther Adv Vaccines Immunother. 2021; 9:25151355211059791.
PMID: 34870090
PMC: 8637774.
DOI: 10.1177/25151355211059791.
A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection.
Counoupas C, Johansen M, Stella A, Nguyen D, Ferguson A, Aggarwal A
NPJ Vaccines. 2021; 6(1):143.
PMID: 34848711
PMC: 8633321.
DOI: 10.1038/s41541-021-00406-4.
Potential global impacts of alternative dosing regimen and rollout options for the ChAdOx1 nCoV-19 vaccine.
Aguas R, Bharath A, White L, Gao B, Pollard A, Voysey M
Nat Commun. 2021; 12(1):6370.
PMID: 34737262
PMC: 8569205.
DOI: 10.1038/s41467-021-26449-8.
Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo.
Hitchings M, Ranzani O, Dorion M, DAgostini T, Paula R, de Paula O
Nat Commun. 2021; 12(1):6220.
PMID: 34711813
PMC: 8553924.
DOI: 10.1038/s41467-021-26459-6.
Inhibition of receptor-binding domain-ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS-CoV-2 vaccines.
Silva V, Yamashiro R, Ahagon C, de Campos I, de Oliveira I, de Oliveira E
J Med Virol. 2021; 94(3):1217-1223.
PMID: 34647623
PMC: 8662120.
DOI: 10.1002/jmv.27396.
Application of quantitative systems pharmacology to guide the optimal dosing of COVID-19 vaccines.
Giorgi M, Desikan R, van der Graaf P, Kierzek A
CPT Pharmacometrics Syst Pharmacol. 2021; 10(10):1130-1133.
PMID: 34331834
PMC: 8420530.
DOI: 10.1002/psp4.12700.
